The demand for weight-loss medications has seen an unprecedented surge in the last year, fueled by rising obesity rates and the growing popularity of GLP-1s like Zepbound and Wegovy. According to data from the CDC, obesity currently affects 4 out of 10 Americans – and, even more striking, by 2030, the obesity rate among U.S. adults is expected to surpass 50% in 29 states.

As awareness of obesity-related health risks and the available solutions to address them grows, employees are increasingly seeking comprehensive obesity and weight health care benefits, including employer-sponsored access to weight-loss medications. Per research from Tebra, 52% of professionals want weight-loss drugs covered in their health benefits – with 1 in 16 saying they would be willing to forgo vacation days in exchange for employers meeting this demand.

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

  • Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.